IRIS
DI IOIA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.645
EU - Europa 1.394
AS - Asia 756
SA - Sud America 86
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
AF - Africa 3
Totale 3.896
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.630
CN - Cina 315
IE - Irlanda 225
IT - Italia 210
DE - Germania 209
SG - Singapore 203
UA - Ucraina 180
TR - Turchia 154
GB - Regno Unito 150
SE - Svezia 138
FI - Finlandia 104
FR - Francia 91
BR - Brasile 77
IN - India 49
RU - Federazione Russa 32
CZ - Repubblica Ceca 18
CA - Canada 13
BE - Belgio 12
EU - Europa 7
CH - Svizzera 6
HK - Hong Kong 6
VN - Vietnam 6
AU - Australia 5
PK - Pakistan 5
IR - Iran 4
PL - Polonia 3
RS - Serbia 3
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
DK - Danimarca 2
GR - Grecia 2
KR - Corea 2
MX - Messico 2
PY - Paraguay 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
CL - Cile 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
NL - Olanda 1
PH - Filippine 1
RO - Romania 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.896
Salva come PNG Salva come JPEG
Città #
Chandler 288
Jacksonville 251
Dublin 222
Singapore 133
Munich 117
Southend 116
Princeton 94
The Dalles 88
Ashburn 85
Nanjing 85
Ann Arbor 76
Izmir 73
Chieti 71
Beijing 69
Dearborn 62
Helsinki 52
Wilmington 40
Cambridge 39
New York 36
Santa Clara 33
Altamura 32
Nanchang 29
Boardman 21
Washington 18
Woodbridge 18
Los Angeles 17
Grevenbroich 15
Brno 14
Kunming 14
Shenyang 13
Brussels 12
Guangzhou 12
Jiaxing 12
Hebei 11
Norwalk 11
Tianjin 11
Turku 10
Hangzhou 9
San Mateo 8
Changsha 7
Frankfurt am Main 7
Houston 7
London 7
Monmouth Junction 7
Nuremberg 7
Dong Ket 6
Falls Church 6
Fribourg 6
Hong Kong 6
Jinan 6
Lanzhou 6
Camerino 5
Pescara 5
Roseto Degli Abruzzi 5
San Francisco 5
São Paulo 5
Toronto 5
Changchun 4
Curitiba 4
Edinburgh 4
Hanover 4
Montesilvano Marina 4
Montreal 4
Olomouc 4
San Vito Chietino 4
Seattle 4
Teramo 4
Zhengzhou 4
Ankara 3
Ardabil 3
Augusta 3
Belgrade 3
La Spezia 3
Milan 3
Mumbai 3
Ningbo 3
Rome 3
Taizhou 3
Tatura 3
Torino 3
Benevento 2
Boston 2
Campodipietra 2
Copenhagen 2
Council Bluffs 2
Dallas 2
Düsseldorf 2
Fairfield 2
Goiânia 2
Istanbul 2
Jyväskylä 2
Karachi 2
Kraków 2
L'aquila 2
Leawood 2
Manchester 2
Moscow 2
Padova 2
Palermo 2
Paulínia 2
Totale 2.545
Salva come PNG Salva come JPEG
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 292
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 155
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 135
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 118
Cleavage of cystatin C is not associated with multiple sclerosis 117
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 109
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 108
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 108
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 103
Increasing age at disability milestones among MS patients in the MSBase Registry 100
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 97
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 97
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 96
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 96
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 96
Data of safety in a single-center alemtuzumab treated population 90
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 89
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 86
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 86
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 85
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 83
Nail loss after teriflunomide treatment: a new potential adverse event 80
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 78
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 78
JCV-Ab serostatus in MS patients treated with Natalizumab 77
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 77
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 77
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 75
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 75
Natalizumab-associated PML-IRIS: the Chieti experience. 75
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 73
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 73
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 72
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group 72
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 72
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 70
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 70
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 69
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 67
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 65
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 59
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 57
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 52
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients 51
Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients. 51
Totale 4.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 0 0 0 0 0 15
2020/2021283 46 3 59 3 5 52 5 0 41 25 30 14
2021/2022232 4 4 9 42 9 13 10 20 16 9 24 72
2022/2023757 61 109 43 74 93 133 34 54 104 15 24 13
2023/2024394 17 18 33 6 30 181 48 5 1 8 2 45
2024/2025846 50 103 110 11 23 63 94 52 103 44 164 29
Totale 4.011